Ser96Ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.
BACKGROUND:Atrial fibrillation (AF) recurrence after radiofrequency catheter ablation (RFCA) still remains a serious issue. Ca2+ handling has a considerable effect on AF recurrence. The histidine-rich calcium-binding protein (HRC) genetic single nucleotide polymorphism (SNP), rs3745297 (T>G, Ser9...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0213208 |
id |
doaj-9c1ae919e3874c8db5127d5552f12154 |
---|---|
record_format |
Article |
spelling |
doaj-9c1ae919e3874c8db5127d5552f121542021-03-03T20:50:15ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01143e021320810.1371/journal.pone.0213208Ser96Ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.Michitaka AmiokaYukiko NakanoHidenori OchiYuko OnoharaAkinori SairakuTakehito TokuyamaChikaaki MotodaHiroya MatsumuraShunsuke TomomoriNaoya HironobeYousaku OkuboSho OkamuraKazuaki ChayamaYasuki KiharaBACKGROUND:Atrial fibrillation (AF) recurrence after radiofrequency catheter ablation (RFCA) still remains a serious issue. Ca2+ handling has a considerable effect on AF recurrence. The histidine-rich calcium-binding protein (HRC) genetic single nucleotide polymorphism (SNP), rs3745297 (T>G, Ser96Ala), is known to cause a sarcoplasmic reticulum Ca2+ leak. We investigated the association between HRC Ser96Ala and AF recurrence after RFCA in paroxysmal AF (PAF) patients. METHODS AND RESULTS:We enrolled PAF patients who underwent RFCA (N = 334 for screening and N = 245 for replication) and were genotyped for HRC SNP (rs3745297). The patient age was younger and rate of diabetes and hypertension lower in the PAF patients with Ser96Ala than in those without (TT/TG/GG, 179/120/35; 64±10/60±12/59±13 y, P = 0.001; 18.5/ 9.2/8.6%, P = 0.04 and 66.1/50.0/37.1%, P = 0.001, respectively). During a mean 19 month follow-up, 57 (17.1%) patients suffered from AF recurrences. The rate of an Ser96Ala was significantly higher in patients with AF recurrence than in those without in the screening set (allele frequency model: odds ratio [OR], 1.80; P = 0.006). We also confirmed this significant association in the replication set (OR 1.74; P = 0.03) and combination (P = 0.0008). A multivariate analysis revealed that the AF duration, sinus node dysfunction, and HRC Ser96Ala were independent predictors of an AF recurrence (hazard ratio [HR], 1.04, P = 0.037; HR 2.42, P = 0.018; and HR 2.66, P = 0.007, respectively). CONCLUSION:HRC SNP Ser96Ala is important as a new genetic marker of AF recurrence after RFCA.https://doi.org/10.1371/journal.pone.0213208 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Michitaka Amioka Yukiko Nakano Hidenori Ochi Yuko Onohara Akinori Sairaku Takehito Tokuyama Chikaaki Motoda Hiroya Matsumura Shunsuke Tomomori Naoya Hironobe Yousaku Okubo Sho Okamura Kazuaki Chayama Yasuki Kihara |
spellingShingle |
Michitaka Amioka Yukiko Nakano Hidenori Ochi Yuko Onohara Akinori Sairaku Takehito Tokuyama Chikaaki Motoda Hiroya Matsumura Shunsuke Tomomori Naoya Hironobe Yousaku Okubo Sho Okamura Kazuaki Chayama Yasuki Kihara Ser96Ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation. PLoS ONE |
author_facet |
Michitaka Amioka Yukiko Nakano Hidenori Ochi Yuko Onohara Akinori Sairaku Takehito Tokuyama Chikaaki Motoda Hiroya Matsumura Shunsuke Tomomori Naoya Hironobe Yousaku Okubo Sho Okamura Kazuaki Chayama Yasuki Kihara |
author_sort |
Michitaka Amioka |
title |
Ser96Ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation. |
title_short |
Ser96Ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation. |
title_full |
Ser96Ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation. |
title_fullStr |
Ser96Ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation. |
title_full_unstemmed |
Ser96Ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation. |
title_sort |
ser96ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2019-01-01 |
description |
BACKGROUND:Atrial fibrillation (AF) recurrence after radiofrequency catheter ablation (RFCA) still remains a serious issue. Ca2+ handling has a considerable effect on AF recurrence. The histidine-rich calcium-binding protein (HRC) genetic single nucleotide polymorphism (SNP), rs3745297 (T>G, Ser96Ala), is known to cause a sarcoplasmic reticulum Ca2+ leak. We investigated the association between HRC Ser96Ala and AF recurrence after RFCA in paroxysmal AF (PAF) patients. METHODS AND RESULTS:We enrolled PAF patients who underwent RFCA (N = 334 for screening and N = 245 for replication) and were genotyped for HRC SNP (rs3745297). The patient age was younger and rate of diabetes and hypertension lower in the PAF patients with Ser96Ala than in those without (TT/TG/GG, 179/120/35; 64±10/60±12/59±13 y, P = 0.001; 18.5/ 9.2/8.6%, P = 0.04 and 66.1/50.0/37.1%, P = 0.001, respectively). During a mean 19 month follow-up, 57 (17.1%) patients suffered from AF recurrences. The rate of an Ser96Ala was significantly higher in patients with AF recurrence than in those without in the screening set (allele frequency model: odds ratio [OR], 1.80; P = 0.006). We also confirmed this significant association in the replication set (OR 1.74; P = 0.03) and combination (P = 0.0008). A multivariate analysis revealed that the AF duration, sinus node dysfunction, and HRC Ser96Ala were independent predictors of an AF recurrence (hazard ratio [HR], 1.04, P = 0.037; HR 2.42, P = 0.018; and HR 2.66, P = 0.007, respectively). CONCLUSION:HRC SNP Ser96Ala is important as a new genetic marker of AF recurrence after RFCA. |
url |
https://doi.org/10.1371/journal.pone.0213208 |
work_keys_str_mv |
AT michitakaamioka ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation AT yukikonakano ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation AT hidenoriochi ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation AT yukoonohara ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation AT akinorisairaku ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation AT takehitotokuyama ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation AT chikaakimotoda ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation AT hiroyamatsumura ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation AT shunsuketomomori ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation AT naoyahironobe ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation AT yousakuokubo ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation AT shookamura ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation AT kazuakichayama ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation AT yasukikihara ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation |
_version_ |
1714820273910317056 |